|Calculated MW||21973 Da|
|Application & Usage||The peptide is used for blocking the antibody activity of Bcl-B. It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30-60 minutes at 37°C.|
|Other Names||Bcl-2-like protein 10, Bcl2-L-10, Anti-apoptotic protein NrH, Apoptosis regulator Bcl-B, BCL2L10, BCLB|
|Formulation||50 µg (0.5 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 1% BSA and 0.02% thimerosal.|
|Reconstitution & Storage||-20 °C|
|Precautions||Bcl-B Blocking Peptide is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Promotes cell survival. Suppresses apoptosis induced by BAX but not BAK.|
|Cellular Location||Mitochondrion. Nucleus membrane|
|Tissue Location||Widely expressed in adult tissues. Preferentially expressed in lung, liver and kidney|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have any additional inquiries please email technical services at email@example.com.